Alkylating agents - PDFSEARCH.IO - Document Search Engine

Alkylating agents
Results: 211

#	Item
111	Division of Pediatric Drug Development Add to Reading List Source URL: www.fda.gov Language: English - Date: 2005-11-17 15:21:48 Carboplatin Hepatology Hepatic veno-occlusive disease Food and Drug Administration Chemistry Alkylating antineoplastic agents Ammine complexes
112	Abstract 190 Pediatric Preclinical Testing Program (PPTP) evaluation of rapamycin combined with cytotoxic drugs used frequently in treatment of childhood cancer Peter J. Houghton1, Christopher Morton1 , John M. Maris 2, Add to Reading List Source URL: pptp.nchresearch.org Language: English - Date: 2009-11-02 10:46:18 Immunosuppressants Lactams Sirolimus Cisplatin Vincristine Mammalian target of rapamycin Cyclophosphamide Maximum tolerated dose Chemistry Alkylating antineoplastic agents Macrolides
113	Priority Substances List Assessment Report for Bis(Chloromethyl) Ether and Chloromethyl Methyl Ether Add to Reading List Source URL: hc-sc.gc.ca Language: English - Date: 2013-07-09 12:17:51 Organochlorides Alkylating agents Chloroalkyl ether Chloromethyl methyl ether General anesthetics Bis(chloromethyl) ether C2H5ClO Canadian Environmental Protection Act Diethyl ether Chemistry Organic chemistry Ethers
114	CMS Manual System Department of Health & Human Services (DHHS) Pub[removed]Medicare National Coverage Add to Reading List Source URL: www.cms.gov Language: English - Date: 2014-04-15 16:12:23 Alkylating antineoplastic agents Oncology Organofluorides Antiemetics Cancer treatments Chemotherapy-induced nausea and vomiting Aprepitant Chemotherapy Cisplatin Chemistry Medicine Organic chemistry
115	https://www.iupui.edu/~cancint/crd/admin/abstract_book.php Add to Reading List Source URL: cancer.iu.edu Language: English - Date: 2014-09-02 07:53:55 T cells Carcinogenesis Alkylating antineoplastic agents Ammine complexes Carcinogens Cancer stem cell Cellular differentiation Glioblastoma multiforme Neurofibroma Biology Medicine Oncology
116	PRIOR AUTHORIZATION POLICY Revlimid® (lenalidomide capsules Celgene) To Initiate a Coverage Review, Call[removed] Add to Reading List Source URL: statehealthplan.state.nc.us Language: English - Date: 2014-04-24 08:24:11 Hematologic neoplasms Lymphoma Orphan drugs Alkylating antineoplastic agents Lenalidomide Multiple myeloma Mantle cell lymphoma Myelodysplastic syndrome Celgene Medicine Oncology Immunosuppressants
117	HIGHLIGHTS OF PRESCRIBING INFORMATION ------------------------------ CONTRA IND I CA TI ONS ----------------------------Patients with a known hypersensitivity to gemcitabine (4) These highlights do not include all the i Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2011-02-09 12:38:58 Eli Lilly and Company Ammine complexes Cancer treatments Organofluorides Carboplatin Gemcitabine Adjuvant therapy Cisplatin Methadone Chemistry Medicine Alkylating antineoplastic agents
118	Laboratory Animal & Molecular Pathology TOXICOLOGIC PATHOLOGY, vol 29, no 6, pp 639– 652, 2001 Copyright C 2001 by the Society of Toxicologic Pathology REVIEW ARTICLE Add to Reading List Source URL: toxnet.nlm.nih.gov Language: English - Date: 2012-11-17 17:24:27 Functional groups Alkylating antineoplastic agents Nitroso Amine Diazo Streptozotocin Chemistry Organic chemistry Nitroso compounds
119	AMERICAN ACADEMY OF OTOLARYNGOLOGY- Add to Reading List Source URL: www.ahns.info Language: English - Date: 2013-01-14 15:59:04 Carcinogenesis Alkylating antineoplastic agents Ammine complexes Lung cancer Carcinogens Squamous-cell carcinoma Cisplatin Glycolysis Medicine Oncology Chemistry
120	1 • HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ALIMTA safely and effectively. See full prescribing information for Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-01-22 11:18:48 Organic chemistry Antifolates Benzamides Pemetrexed Organofluorides Alkylating antineoplastic agents Cisplatin Mesothelioma Gemcitabine Chemistry Eli Lilly and Company Medicine

UPDATE